Christopher J. Ott

6.8k total citations · 1 hit paper
46 papers, 2.9k citations indexed

About

Christopher J. Ott is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher J. Ott has authored 46 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Hematology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher J. Ott's work include Protein Degradation and Inhibitors (22 papers), Genomics and Chromatin Dynamics (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Christopher J. Ott is often cited by papers focused on Protein Degradation and Inhibitors (22 papers), Genomics and Chromatin Dynamics (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Christopher J. Ott collaborates with scholars based in United States, China and Switzerland. Christopher J. Ott's co-authors include James E. Bradner, Kwok‐Kin Wong, Gang Lu, Richard E. Middleton, Huahang Sun, William G. Kaelin, Constantine S. Mitsiades, Ann Harris, Jake Shortt and Ricky W. Johnstone and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Christopher J. Ott

43 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

2013 1.1k citations Gang Lu, Richard E. Middleton et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Ott United States	20	2.4k	903	772	303	246	46	2.9k
Péter Sandy United States	17	3.0k 1.3×	629 0.7×	994 1.3×	258 0.9×	203 0.8×	27	3.5k
Matty Verlaan–de Vries Netherlands	17	1.7k 0.7×	294 0.3×	755 1.0×	178 0.6×	172 0.7×	24	2.2k
Joachim Schwäble Germany	22	1.2k 0.5×	1.1k 1.2×	487 0.6×	259 0.9×	105 0.4×	33	2.1k
Katharina Blatt Austria	26	1.8k 0.8×	1.0k 1.1×	447 0.6×	407 1.3×	82 0.3×	58	3.2k
Jason S. Damiano United States	13	1.0k 0.4×	653 0.7×	753 1.0×	379 1.3×	78 0.3×	15	1.8k
Stefan Glaser Australia	23	1.9k 0.8×	465 0.5×	472 0.6×	650 2.1×	52 0.2×	34	2.6k
Madhavi Bandi United States	11	1.2k 0.5×	485 0.5×	734 1.0×	236 0.8×	58 0.2×	20	1.9k
David Taussig United Kingdom	22	1.6k 0.7×	1.7k 1.9×	951 1.2×	769 2.5×	92 0.4×	56	3.2k
Raluca Verona United States	26	2.0k 0.8×	688 0.8×	1.5k 1.9×	513 1.7×	92 0.4×	61	3.2k
Giorgia Simonetti Italy	25	1.0k 0.4×	377 0.4×	520 0.7×	778 2.6×	106 0.4×	91	2.2k

Countries citing papers authored by Christopher J. Ott

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Ott more than expected).

Fields of papers citing papers by Christopher J. Ott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Ott. The network helps show where Christopher J. Ott may publish in the future.

Co-authorship network of co-authors of Christopher J. Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Ott. A scholar is included among the top collaborators of Christopher J. Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Ott. Christopher J. Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Egan, Regina K., Jianli Ma, Jong Kung, et al.. (2025). Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models. Molecular Cancer Therapeutics. 24(6). 920–930. 1 indexed citations

Cooper, Mark S., Sean Goggins, Steven Reynolds, et al.. (2025). Development of p300-targeting degraders with enhanced selectivity and onset of degradation. RSC Medicinal Chemistry. 16(5). 2049–2060. 1 indexed citations

Godfrey, Laura, Charlie Hatton, Daniela V. Wenge, et al.. (2025). p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma. EMBO Reports. 26(19). 4766–4793. 1 indexed citations

Cironi, Luisa, Viviane Praz, Rajendran Sanalkumar, et al.. (2024). CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas. Cancers. 16(2). 457–457. 5 indexed citations

Vannam, Raghu, et al.. (2024). Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity. Bioorganic & Medicinal Chemistry Letters. 102. 129676–129676. 2 indexed citations

Zhang, Yuxiang, David Remillard, Joshua N. Asiaban, et al.. (2023). Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. Nature Structural & Molecular Biology. 30(8). 1160–1171. 15 indexed citations

Vannam, Raghu, Eileen Hu, Johannes Kreuzer, et al.. (2021). Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell chemical biology. 28(4). 503–514.e12. 102 indexed citations

Wang, Haichuan, Raj Bandaru, Matthew A. Lawlor, et al.. (2021). Selective targeting of MYC mRNA by stabilized antisense oligonucleotides. Oncogene. 40(47). 6527–6539. 10 indexed citations

Peeken, Jan C., Jonas S. Jutzi, Julius Wehrle, et al.. (2018). Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood. 131(18). 2065–2073. 35 indexed citations

10.

Buckley, Dennis L., Matthew A. Lawlor, Jaime M. Reyes, et al.. (2018). Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands. Nature Chemical Biology. 14(4). 405–412. 167 indexed citations

11.

Ott, Christopher J., Alexander Federation, Siddha Kasar, et al.. (2018). Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell. 34(6). 982–995.e7. 75 indexed citations

12.

Shortt, Jake, Christopher J. Ott, Ricky W. Johnstone, & James E. Bradner. (2017). A chemical probe toolbox for dissecting the cancer epigenome. Nature reviews. Cancer. 17(3). 160–183. 70 indexed citations

13.

Lu, Gang, Richard E. Middleton, Huahang Sun, et al.. (2013). The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins. Science. 343(6168). 305–309. 1108 indexed citations breakdown →

14.

Bischof, Jared M., Christopher J. Ott, Shih‐Hsing Leir, et al.. (2011). A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function. Thorax. 67(5). 385–391. 23 indexed citations

15.

Zhang, Zhaolin, Christopher J. Ott, Marzena Anna Lewandowska, Shih‐Hsing Leir, & Ann Harris. (2011). Molecular mechanisms controlling CFTR gene expression in the airway. Journal of Cellular and Molecular Medicine. 16(6). 1321–1330. 33 indexed citations

16.

Ott, Christopher J., et al.. (2011). Nucleosome occupancy reveals regulatory elements of the CFTR promoter. Nucleic Acids Research. 40(2). 625–637. 8 indexed citations

17.

Ott, Christopher J., et al.. (2009). Interaction of intestinal and pancreatic transcription factors in the regulation of CFTR gene expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1789(11-12). 709–718. 10 indexed citations

18.

Blackledge, Neil P., Christopher J. Ott, Austin E. Gillen, & Ann Harris. (2009). An insulator element 3′ to the CFTR gene binds CTCF and reveals an active chromatin hub in primary cells. Nucleic Acids Research. 37(4). 1086–1094. 51 indexed citations

19.

Ott, Christopher J., et al.. (2008). A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter. Journal of Cellular and Molecular Medicine. 13(4). 680–692. 58 indexed citations

20.

Elkahwaji, Johny E., et al.. (2005). Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology. 66(4). 883–887. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact